Cargando…

Treatment of refractory Yao syndrome with canakinumab

Detalles Bibliográficos
Autores principales:	Brailsford, Caroline J., Khamdan, Fatima, Elston, Dirk M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9522865/ https://www.ncbi.nlm.nih.gov/pubmed/36186408 http://dx.doi.org/10.1016/j.jdcr.2022.08.035

Ejemplares similares

Successful treatment of refractory hyperferritinemic syndromes with canakinumab: a report of two cases
por: Papa, Riccardo, et al.
Publicado: (2020)

Canakinumab for refractory RA: a case report
por: Marketos, Nikolaos, et al.
Publicado: (2018)

Canakinumab as rescue therapy in familial Mediterranean fever refractory to conventional treatment
por: Alpa, Mirella, et al.
Publicado: (2015)

Canakinumab for the treatment of different refractory autoinflammatory disorders
por: Grein, Ingrid HR, et al.
Publicado: (2014)

Case report on the use of canakinumab for treatment of recurrent fevers and proteinuria in refractory systemic lupus erythematosus
por: Yavari, Kimia, et al.
Publicado: (2023)

Yao syndrome: Cyclical folliculitis, fevers, and abdominal pain
por: Esse, Ilhan, et al.
Publicado: (2023)

Expedited Desensitization to Canakinumab
por: Sanan, Neha, et al.
Publicado: (2020)

A Case of Hyperimmunoglobulinemia D Syndrome Successfully Treated with Canakinumab
por: Tsitsami, Elena, et al.
Publicado: (2013)

Increasing the Interval of Canakinumab Administration Effectively Supports the Remission of Schnitzler's Syndrome
por: Gorodetskiy, Vadim R., et al.
Publicado: (2018)

Yao Syndrome: A Potential Role and Association of Vasoactive Intestinal Peptide with NOD2
por: Navetta-Modrov, Brianne, et al.
Publicado: (2021)

A case of Schnitzler’s syndrome without monoclonal gammopathy successfully treated with canakinumab
por: Fujita, Yuya, et al.
Publicado: (2021)

Live‐attenuated vaccines in a cryopyrin‐associated periodic syndrome patient receiving canakinumab treatment during infancy
por: Watanabe, Misa, et al.
Publicado: (2017)

Modified Tong Xie Yao Fang relieves solitary rectal ulcer syndrome: A case report
por: Zhang, Li-Li, et al.
Publicado: (2019)

Canakinumab: Pulmonary bacterial superinfection secondary to compassionate use: case report
Publicado: (2021)

Treatment of systemic-onset juvenile arthritis with canakinumab
por: Peitz, Joachim, et al.
Publicado: (2015)

Canakinumab and cardiovascular outcomes: results of the CANTOS trial
por: Shah, Syed Raza, et al.
Publicado: (2018)

A case report of locally invasive Aspergillus fumigatus infection in a patient on canakinumab
por: Chandrakumaran, Anchalia, et al.
Publicado: (2018)

PReS-FINAL-2330: Canakinumab treatment in patients with HIDS
por: Antón, J, et al.
Publicado: (2013)

Improvement of Liver Involvement in Familial Mediterranean Fever After the Introduction of Canakinumab: A Case Report
por: Massaro, Maria Grazia, et al.
Publicado: (2020)

Clinical experiences with canakinumab as a treatment for autoinflammatory disorders
por: Saperia, C, et al.
Publicado: (2015)

Critical appraisal of canakinumab in the treatment of adults and children with cryopyrin-associated periodic syndrome (CAPS)
por: Toker, Ori, et al.
Publicado: (2010)

Interleukin-1 receptor antagonist deficiency with a novel mutation; late onset and successful treatment with canakinumab: a case report
por: Ulusoy, Ezgi, et al.
Publicado: (2015)

The experience of canakinumab in renal amyloidosis secondary to Familial Mediterranean fever
por: Sozeri, Betul, et al.
Publicado: (2016)

Effectiveness of canakinumab treatment in Schnitzler's syndrome: a multi-center randomized placebo-controlled study
por: Krause, K, et al.
Publicado: (2015)

Early Treatment of Systemic Juvenile Idiopathic Arthritis with Canakinumab and Complete Remission After 2 Years of Treatment Suspension: Case Report of an Adolescent Girl
por: Maggio, Maria Cristina, et al.
Publicado: (2019)

OR10-006 - Canakinumab in patients with TRAPS
por: Lachmann, HJ, et al.
Publicado: (2013)

A Cluster of Rhabdomyolysis Syndrome Resulting from Carp Consumption in Gongcheng Yao Autonomous County, Guangxi, 2016
por: Zeng, Jinshui, et al.
Publicado: (2020)

PW02-041 - Canakinumab treatment regimens in CAPS-patients
por: Hofer, F, et al.
Publicado: (2013)

PReS-FINAL-2224: Canakinumab treatment regimens in CAPS-patients
por: Hofer, F, et al.
Publicado: (2013)

Canakinumab and Lung Cancer: Intriguing, but Is It Real?
por: Chabner, Bruce A., et al.
Publicado: (2018)

Acromegaly Presenting with Resistant Acne Vulgaris
por: Khamdan, Fatema Abdulwahab, et al.
Publicado: (2022)

The complete mitochondrial genome of Yao silkworm (Bombyx mori)
por: Zhang, Gui-Zheng, et al.
Publicado: (2019)

Case Report: Canakinumab for the Treatment of a Patient With COVID-19 Acute Respiratory Distress Syndrome
por: Caracciolo, Massimo, et al.
Publicado: (2020)

NOD2 Versus MEFV: Differential Diagnosis of Yao Syndrome and Familial Mediterranean Fever
por: Yao, Qingping, et al.
Publicado: (2021)

Systemic autoimmune disease in asbestosis rapidly responding to anti-interleukin-1beta antibody canakinumab: a case report
por: Niccoli, Laura, et al.
Publicado: (2015)

Rituximab and Canakinumab Use During Lactation: No Detectable Serum Levels in Breastfed Infants
por: Bosshard, Nicole, et al.
Publicado: (2021)

Canakinumab and mycophenolate mofetil in managing proteinuria/renal amyloidosis secondary to adult-onset Still’s disease
por: Feng, Jin, et al.
Publicado: (2023)

PW01-012 – Canakinumab in patients with FMF
por: Ugurlu, S, et al.
Publicado: (2013)

Canakinumab therapy in patients with Familial Mediterranean Fever
por: Ugurlu, S, et al.
Publicado: (2015)

Canakinumab in a subgroup of patients with COVID-19
por: Ucciferri, Claudio, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_tf3sobdm6edr6rpt970m75j6s2